Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avadel Pharmaceuticals plc

10.83
-0.0100-0.09%
Post-market: 10.830.00000.00%17:09 EDT
Volume:1.24M
Turnover:13.50M
Market Cap:1.05B
PE:-39.52
High:11.09
Open:11.01
Low:10.70
Close:10.84
Loading ...

Avadel Pharmaceuticals Plc : H.c. Wainwright Assumes Coverage With Buy Rating; Price Target $22

THOMSON REUTERS
·
18 Jul

Shareholder Activism Intensifies as Avadel Pharmaceuticals Faces Governance Challenges Ahead of Annual Meeting

Reuters
·
14 Jul

ASL pushes for board shakeup at Avadel over handling of sleep drug rollout

Reuters
·
30 Jun

Avadel Faces Proxy Challenge Over Alleged Lumryz Launch 'Missteps'

MT Newswires Live
·
30 Jun

Avadel announces appeals court decision upholding FDA approval of LUMRYZ

TIPRANKS
·
30 Jun

BRIEF-Asl Strategic Value Fund Issues Open Letter To Avadel Shareholders

Reuters
·
30 Jun

BRIEF-Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval Of Lumryz

Reuters
·
30 Jun

Avadel Pharmaceuticals' Contingent Value Rights Could Yield Over $1 Billion from Jazz Pharmaceuticals Lawsuits

Reuters
·
30 Jun

ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders

THOMSON REUTERS
·
30 Jun

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of Lumryz in Narcolepsy in Administrative Procedure Act Litigation

THOMSON REUTERS
·
30 Jun

Stocks to Watch: NextEra, Juniper, HPE, SunRun -- WSJ

Dow Jones
·
30 Jun

PRESS DIGEST- Wall Street Journal - June 30

Reuters
·
30 Jun

BRIEF-Avadel Shareholder Seeks Ousting Drugmaker's Entire Board- WSJ

Reuters
·
30 Jun

Avadel Shareholder Seeks Ousting Drugmaker’s Entire Board- WSJ

THOMSON REUTERS
·
30 Jun

ASL Strategic Value Fund Seeks to Oust Avadel’s Board, Alleging Mismanagement of Lumryz - WSJ

THOMSON REUTERS
·
30 Jun

Avadel Pharmaceuticals Plc - D.c. Court of Appeals Upholds FDA Approval of Lumryz - SEC Filing

THOMSON REUTERS
·
28 Jun

Avadel Pharmaceuticals Triumphs as D.C. Court of Appeals Upholds FDA Approval of LUMRYZ

Reuters
·
28 Jun

BRIEF-Avadel announces grant of inducement awards under Nasdaq listing rule

Reuters
·
17 Jun

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
17 Jun

Avadel Pharmaceuticals Gets Orphan Drug Designation for Lumryz to Treat Idiopathic Hypersomnia

MT Newswires Live
·
05 Jun